These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33883930)

  • 1. The Inclusion of Tolfenamic Acid into Cyclodextrins Stimulated by Microenvironmental pH Modification as a Way to Increase the Anti-Migraine Effect.
    Stasiłowicz A; Tykarska E; Rosiak N; Sałat K; Furgała-Wojas A; Plech T; Lewandowska K; Pikosz K; Pawłowicz K; Cielecka-Piontek J
    J Pain Res; 2021; 14():981-992. PubMed ID: 33883930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Systems of Naringenin with Solubilizers Expand Its Capability to Prevent Neurodegenerative Diseases.
    Stasiłowicz-Krzemień A; Gołębiewski M; Płazińska A; Płaziński W; Miklaszewski A; Żarowski M; Adamska-Jernaś Z; Cielecka-Piontek J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid.
    Stasiłowicz-Krzemień A; Rosiak N; Płazińska A; Płaziński W; Miklaszewski A; Tykarska E; Cielecka-Piontek J
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility, Permeability, Anti-Inflammatory Action and In Vivo Pharmacokinetic Properties of Several Mechanochemically Obtained Pharmaceutical Solid Dispersions of Nimesulide.
    Wei W; Evseenko VI; Khvostov MV; Borisov SA; Tolstikova TG; Polyakov NE; Dushkin AV; Xu W; Min L; Su W
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY; Hsu CH; Sheu MT
    J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
    Gladys G; Claudia G; Marcela L
    Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of Freeze-Dried Amorphous Vardenafil Hydrochloride with Saccharides as a Way to Enhance Dissolution Rate and Permeability.
    Wiergowska G; Ludowicz D; Wdowiak K; Miklaszewski A; Lewandowska K; Cielecka-Piontek J
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34064796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice.
    Latrofa A; Trapani G; Franco M; Serra M; Muggironi M; Fanizzi FP; Cutrignelli A; Liso G
    Eur J Pharm Biopharm; 2001 Jul; 52(1):65-73. PubMed ID: 11438425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies.
    Cappello B; di Maio C; Iervolino M; Miro A; Calignano A
    Drug Dev Ind Pharm; 2009 Jul; 35(7):877-86. PubMed ID: 19466892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous Inclusion Complexes: Molecular Interactions of Hesperidin and Hesperetin with HP-Β-CD and Their Biological Effects.
    Wdowiak K; Rosiak N; Tykarska E; Żarowski M; Płazińska A; Płaziński W; Cielecka-Piontek J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
    Garg A; Gupta B; Prakash R; Singh S
    Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.